SEL120 monohydrochloride, Votubia 5 mg tablets, Votubia 2.5 mg tablets, Certican, 0,5 mg, tabletki, SEL120 monohydrochloride clinical trials

Phase I study of CDK8 inhibitor RVU120 in combination with everolimus in children with recurrent or progressive Group 3 or 4 medulloblastoma; MEDWAY

This study, called MEDWAY, is looking at a new medicine, RVU120, alone and with another drug, everolimus. It's for children with a type of brain cancer called medulloblastoma that has come back or is getting worse. We want to find the safest dose and see how well it works.